Skip to main content
OpenTrials

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,796 public trials 830 recruiting studies
Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above

NCT05829356

Conditions
Infections, Influenza Immunization, Influenza, Human, +5 more
Locations
  • Investigational Site Number : 0360004 Herston, Queensland, Australia
  • Investigational Site Number : 0360001 Morayfield, Queensland, Australia
  • Investigational Site Number : 0360002 Camberwell, Victoria, Australia
  • Investigational Site Number : 0360003 Adelaide, Australia
View Trial Details
Completed

Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South Korea

NCT05144945

Conditions
Infections, Influenza (Healthy Volunteers), Influenza, Human, +5 more
Locations
  • Investigational Site Number :4100003 Ansan-si, Gyeonggi-do, South Korea
  • Investigational Site Number :4100001 Seoul, Seoul-teukbyeolsi, South Korea
  • Investigational Site Number :4100002 Seoul, South Korea
View Trial Details
Completed

A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

NCT06680375

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • GSK Investigational Site Anniston, Alabama, United States
  • GSK Investigational Site Rolling Hills Estates, California, United States
  • GSK Investigational Site Hialeah, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
View Trial Details
Completed

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

NCT01773928

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • East Valley Family Physicians, PLC Chandler, Arizona, United States
  • Anaheim Clinical Trials Anaheim, California, United States
  • Center for Clinical Trials, LLC Paramount, California, United States
  • California Research Foundation San Diego, California, United States
View all 20 locations
View Trial Details
Completed

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

NCT06237296

Conditions
Healthy Volunteers, Infections, Metapneumovirus Infection, +7 more
Locations
  • Velocity Gardena Site Number : 8400011 Gardena, California, United States
  • Velocity Clinical Research-Hallandale Beach- Site Number : 8400013 Hallandale, Florida, United States
  • Advanced Clinical Research- Site Number : 8400005 Meridian, Idaho, United States
  • Velocity Clinical Research, Sioux City Site Number : 8400017 Sioux City, Iowa, United States
View all 17 locations
View Trial Details
Completed

Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older

NCT06507553

Conditions
Healthy Volunteers, Infections, Influenza, +6 more
Locations
  • Investigational Site Number : 0360002 Botany, New South Wales, Australia
  • Investigational Site Number : 0360010 Brookvale, New South Wales, Australia
  • Investigational Site Number : 0360012 Maroubra, New South Wales, Australia
  • Investigational Site Number : 0360011 Miranda, New South Wales, Australia
View Trial Details

Related conditions